SNGX =MC $46 M--Moving higher could breakout anytime now SNGX =Mcap $45 M---3x Phase 3 programs+ COVID 19 Vaccine data soon=one of the cheapest biotech out there COVID-19 Vaccine; Zacks Small-Cap Research Increases Valuation To $12.00 Per Share https://finance.yahoo.com/news/soligenix-inc-heat-stabilization-platform-131100640.html Presentation http://ir.soligenix.com/download/Soligenix+Corporate+Presentation+04.30.20.pdf